Pharmacokinetic Study of 4 mg Nicotine Lozenge.
NCT01669122
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Smoking Cessation
Interventions
DRUG:
nicotine
Sponsor
GlaxoSmithKline